Adjusted EBITDA was $506 million, down 24%, with margin at 12%, down 300 basis points due to lower gross profit and reduced operating leverage.
Adjusted EPS was $2.38, down 32%, with share repurchases adding approximately $0.18 per share benefit.
Adjusted SG&A was $818 million, up $4 million, mainly from acquired operations, with 30% fixed and 70% variable costs.
Capital expenditures were $86 million; $61 million deployed on acquisitions; repurchased 3.3 million shares for $391 million.
Gross profit was $1.3 billion, down 11% year-over-year, with gross margin at 30.7%, down 210 basis points due to margin normalization and low starts environment.
Net debt to adjusted EBITDA ratio was about 2.3x, fixed charge coverage ratio roughly 6x; no long-term debt maturities until 2030.
Net sales decreased 5% to $4.2 billion in Q2, driven by lower organic sales and commodity deflation, partially offset by acquisitions.
Operating cash flow was $341 million, down $111 million mainly due to lower net income; free cash flow was $255 million.